Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Mar;53(3):e13909.
doi: 10.1111/eci.13909. Epub 2022 Dec 8.

Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease

Anne M van Dijk  1 , Alexandra S Bruins Slot  2 , Piero Portincasa  3 , Sebastiaan N Siegerink  2 , Najiba Chargi  4 , Carina J R Verstraete  2 , Joep de Bruijne  2 , Frank P Vleggaar  2 , Karel J van Erpecum  2
Affiliations
Meta-Analysis

Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease

Anne M van Dijk et al. Eur J Clin Invest. 2023 Mar.

Abstract

Background: Dietary supplementation with branched-chain amino acids (BCAA) is often used in cirrhotic patients to improve nutritional status. We wanted to explore the evidence for BCAA supplementation in chronic liver disease.

Methods: We searched MEDLINE and EMBASE for studies with BCAA supplementation with the presence of a disease-control group (placebo or no intervention) using search terms 'liver cirrhosis', 'hepatocellular carcinoma', 'branched chain amino acids' and relevant synonyms. Risk of bias was assessed using ROBINS-I and RoB 2.0 tools. Meta-analyses were performed with a random-effects model. Results were reported following EQUATOR guidelines.

Results: Of 3378 studies screened by title and abstract, 54 were included (34 randomized controlled trials, 5 prospective case-control studies, 13 retrospective case-control studies: in total 2308 patients BCAA supplementation, 2876 disease-controls). Risk of bias was high/serious for almost all studies. According to meta-analyses, long-term (at least 6 months) BCAA supplementation in cirrhotic patients significantly improved event-free survival (p = .008; RR .61 95% CI .42-.88) and tended to improve overall survival (p = .05; RR .58 95% CI .34-1.00). Two retrospective studies suggested the beneficial effects during sorafenib for hepatocellular carcinoma. Available studies reported no beneficial effects or contradictory results of BCAA after other specific therapeutic interventions (resection or radiological interventions for hepatocellular carcinoma, liver transplantation, paracentesis or variceal ligation). No convincing beneficial effects of BCAA supplementation on liver function, nutritional status or quality of life were found. No study reported serious side effects of BCAA.

Conclusions: Prophylactic BCAA supplementation appears safe and might improve survival in cirrhotic patients.

Keywords: branched-chain amino acids; cirrhosis; hepatocellular carcinoma; liver; nutrition.

PubMed Disclaimer

References

REFERENCES

    1. Ascione A, Fontanella L, Imparato M, Rinaldi L, De Luca M. Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years. Liver Int. 2017;37(8):1193-1201. doi:10.1111/liv.13371
    1. Guglielmi FW, Panella C, Buda A, et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the “nutritional problems in gastroenterology” section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis. 2005;37(9):681-688. doi:10.1016/j.dld.2005.03.010
    1. Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in patients with liver cirrhosis. Nutrients. 2021;13(2):540. doi:10.3390/nu13020540
    1. Huisman EJ, Trip EJ, Siersema PD, Van Hoek B, Van Erpecum KJ. Protein energy malnutrition predicts complications in liver cirrhosis. Eur J Gastroenterol Hepatol. 2011;23(11):982-989. doi:10.1097/MEG.0b013e32834aa4bb
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660

MeSH terms

Substances

LinkOut - more resources